---
schema_version: "secwatch.filing_event.v1"
accession: "0000021076-24-000038"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:38:06.639835+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Clorox Q1 FY2025: net sales +27% to $1.76B; adj. EPS $1.86 vs $0.49 YoY; raised outlook

## Summary
- Diluted EPS rose 371% to $0.80; adjusted EPS of $1.86 (+280% YoY) on strong ops and cyberattack lapping.
- Organic sales up 31%; volume growth 26% driven by Health & Wellness (+38%), Household (+43%), Lifestyle (+48%).
- Gross margin expanded 740 bps to 45.8% on higher volume and cost savings; FY2025 EPS and margin outlook raised.
- Year-to-date operating cash flow $221M vs $20M a year ago; free cash flow $182M vs -$4M.
- Better Health VMS divestiture completed Sep 10; one-time charge of $0.94/share in reported EPS.

## SEC filing metadata
- accession: 0000021076-24-000038
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000002107624000038/0000021076-24-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000002107624000038/clx-20241030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021076-24-000038
- JSON: https://secwatch.observer/filing/0000021076-24-000038.json
- Plain text: https://secwatch.observer/filing/0000021076-24-000038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.